Immunosuppressive treatment for myocarditis: A meta-analysis of randomized controlled trials

Journal of Cardiovascular Medicine

Volumn 17, Issue 8, 2016, Pages 631-637

  Lu, Cong ^a   Qin, Fang ^a   Yan, Yafei ^a   Liu, Tong ^a   Li, Jing ^b   Chen, Hang ^a  

^a CHENGDU FIRST PEOPLE S HOSPITAL   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Immunosuppressive treatment; meta analysis; myocarditis

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; THYMUS HORMONE;

ARTICLE; CARDIAC PATIENT; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; META ANALYSIS; MYOCARDITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT COURSE THERAPY; SYSTEMATIC REVIEW; DRUG EFFECTS; HEART LEFT VENTRICLE FUNCTION; HYPERTENSION;

HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; MYOCARDITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VENTRICULAR FUNCTION, LEFT;

EID: 84903676814     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000134     Document Type: Article

References (25)

1. D'Ambrosio A, Patti G, Manzoli A, et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 2001; 85:499-504.
2. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99:1091-1100.
3. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001; 104:1076-1082.
4. Howlett JG, McKelvie RS, Arnold JM, et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 2009; 25:85-105.
5. Chan KY, Iwahara M, Benson LN, Wilson GJ, Freedom RM. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol 1991; 17:458-460.
6. Kleinert S, Weitraub RG, Wilkinson JL, Chow CW. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997; 16:1248-1254.
7. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcomes of acute myocarditis in childhood. Heart 1999; 82:226-233.
8. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995; 333:269-275.
9. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001; 104:39-45.
10. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93:841-842.
11. Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989; 321:1061-1068.
12. Aziz KU, Patel N, Sadullah T, Tasneem H, Thawerani H, Talpur S. Acute viral myocarditis: role of immunosuppression: a prospective randomised study. Cardiol Young 2010; 20:509-515.
13. Latham RD, Mulrow JP, Virmani R, Robinowitz M, Moody JM. Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy. Am Heart J 1989; 117:876-882.
14. Camargo PR, Snitcowsky R, da Luz PL, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995; 16:61-68.
15. Mirić M, Vasiljević JD, Bojić M, et al. Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results. Heart 1996; 75:596-601.
16. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103:2254-2259.
17. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009; 30:1995-2002.
18. Cheng TO. Notes from a recent visitor to Berlin: on myocarditis, effect of coronary angiography on thyroid function, and Virchow's inflammatory theory of atherosclerosis. Am J Cardiol 2002; 89:1011-1012.
19. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987; 18:619-624.
20. Mason JW, Billingham ME, Ricci DR. Treatment of acute inflammatory myocarditis associated by endomyocardial biopsy. Am J Cardiol 1980; 45:1037-1044.
21. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol 2012; 59:779-792.
22. Cooper LT Jr. Myocarditis. N Engl J Med 2009; 360:1526-1538.
23. Schultheiss HP, Kü hl U, Cooper LT. The management of myocarditis. Eur Heart J 2011; 32:2616-2625.
24. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34:2636-2648.
25. Liu C, Chen J, Liu K. Immunosuppressive treatment for inflammatory cardiomyopathy: meta-analysis of randomized controlled trials. Int Heart J 2005; 46:113-122.